nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—MTOR—epilepsy syndrome	0.232	0.74	CbGaD
Tacrolimus—ALB—epilepsy syndrome	0.0417	0.133	CbGaD
Tacrolimus—ABCB1—epilepsy syndrome	0.0398	0.127	CbGaD
Tacrolimus—ALB—Oxcarbazepine—epilepsy syndrome	0.0193	0.0496	CbGbCtD
Tacrolimus—ALB—Fosphenytoin—epilepsy syndrome	0.0169	0.0434	CbGbCtD
Tacrolimus—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0155	0.0399	CbGbCtD
Tacrolimus—ALB—Clonazepam—epilepsy syndrome	0.0153	0.0392	CbGbCtD
Tacrolimus—CYP3A7—Carbamazepine—epilepsy syndrome	0.013	0.0334	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.013	0.0334	CbGbCtD
Tacrolimus—ALB—Rufinamide—epilepsy syndrome	0.0125	0.032	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0117	0.03	CbGbCtD
Tacrolimus—CYP3A7—Phenytoin—epilepsy syndrome	0.0117	0.03	CbGbCtD
Tacrolimus—ABCB1—Levetiracetam—epilepsy syndrome	0.0111	0.0284	CbGbCtD
Tacrolimus—ALB—Phenytoin—epilepsy syndrome	0.0109	0.028	CbGbCtD
Tacrolimus—CYP3A7—Phenobarbital—epilepsy syndrome	0.0104	0.0267	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0104	0.0267	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0103	0.0263	CbGbCtD
Tacrolimus—CYP3A7—Midazolam—epilepsy syndrome	0.0103	0.0263	CbGbCtD
Tacrolimus—ALB—Propofol—epilepsy syndrome	0.0102	0.0261	CbGbCtD
Tacrolimus—CYP3A7—Diazepam—epilepsy syndrome	0.00986	0.0253	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00986	0.0253	CbGbCtD
Tacrolimus—CYP3A5—Carbamazepine—epilepsy syndrome	0.00976	0.0251	CbGbCtD
Tacrolimus—ALB—Diazepam—epilepsy syndrome	0.0092	0.0236	CbGbCtD
Tacrolimus—CYP3A5—Phenytoin—epilepsy syndrome	0.00875	0.0225	CbGbCtD
Tacrolimus—CYP3A5—Phenobarbital—epilepsy syndrome	0.0078	0.02	CbGbCtD
Tacrolimus—CYP3A5—Midazolam—epilepsy syndrome	0.00769	0.0198	CbGbCtD
Tacrolimus—ABCB1—Clobazam—epilepsy syndrome	0.00766	0.0197	CbGbCtD
Tacrolimus—CYP3A5—Diazepam—epilepsy syndrome	0.00739	0.019	CbGbCtD
Tacrolimus—ABCB1—Lamotrigine—epilepsy syndrome	0.00738	0.0189	CbGbCtD
Tacrolimus—ABCB1—Carbamazepine—epilepsy syndrome	0.00635	0.0163	CbGbCtD
Tacrolimus—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00606	0.0156	CbGbCtD
Tacrolimus—CYP3A5—Valproic Acid—epilepsy syndrome	0.00583	0.015	CbGbCtD
Tacrolimus—ABCB1—Phenytoin—epilepsy syndrome	0.00569	0.0146	CbGbCtD
Tacrolimus—CYP3A4—Trimethadione—epilepsy syndrome	0.00563	0.0145	CbGbCtD
Tacrolimus—CYP3A4—Felbamate—epilepsy syndrome	0.00563	0.0145	CbGbCtD
Tacrolimus—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00529	0.0136	CbGbCtD
Tacrolimus—ABCB1—Phenobarbital—epilepsy syndrome	0.00508	0.013	CbGbCtD
Tacrolimus—ABCB1—Midazolam—epilepsy syndrome	0.005	0.0129	CbGbCtD
Tacrolimus—ABCB1—Diazepam—epilepsy syndrome	0.00481	0.0124	CbGbCtD
Tacrolimus—CYP3A4—Clonazepam—epilepsy syndrome	0.00479	0.0123	CbGbCtD
Tacrolimus—CYP3A4—Clobazam—epilepsy syndrome	0.00459	0.0118	CbGbCtD
Tacrolimus—PPP3CA—pons—epilepsy syndrome	0.00438	0.105	CbGeAlD
Tacrolimus—CYP3A4—Rufinamide—epilepsy syndrome	0.0039	0.01	CbGbCtD
Tacrolimus—CYP3A4—Carbamazepine—epilepsy syndrome	0.0038	0.00977	CbGbCtD
Tacrolimus—PPP3CA—telencephalic ventricle—epilepsy syndrome	0.00361	0.0867	CbGeAlD
Tacrolimus—CYP3A4—Primidone—epilepsy syndrome	0.00355	0.00912	CbGbCtD
Tacrolimus—CYP3A4—Phenytoin—epilepsy syndrome	0.00341	0.00876	CbGbCtD
Tacrolimus—CYP3A4—Propofol—epilepsy syndrome	0.00318	0.00817	CbGbCtD
Tacrolimus—MTOR—forelimb—epilepsy syndrome	0.00307	0.0738	CbGeAlD
Tacrolimus—CYP3A4—Phenobarbital—epilepsy syndrome	0.00304	0.00781	CbGbCtD
Tacrolimus—CYP3A4—Acetazolamide—epilepsy syndrome	0.00304	0.00781	CbGbCtD
Tacrolimus—CYP3A4—Midazolam—epilepsy syndrome	0.003	0.0077	CbGbCtD
Tacrolimus—CYP3A4—Diazepam—epilepsy syndrome	0.00288	0.00741	CbGbCtD
Tacrolimus—CYP3A4—Zonisamide—epilepsy syndrome	0.00281	0.00723	CbGbCtD
Tacrolimus—CYP3A4—Valproic Acid—epilepsy syndrome	0.00227	0.00584	CbGbCtD
Tacrolimus—PPP3CA—ganglion—epilepsy syndrome	0.00225	0.054	CbGeAlD
Tacrolimus—CYP3A4—Topiramate—epilepsy syndrome	0.00205	0.00527	CbGbCtD
Tacrolimus—PPP3CA—hindbrain—epilepsy syndrome	0.0017	0.0409	CbGeAlD
Tacrolimus—ABCA5—telencephalon—epilepsy syndrome	0.00128	0.0308	CbGeAlD
Tacrolimus—MTOR—hindbrain—epilepsy syndrome	0.00126	0.0302	CbGeAlD
Tacrolimus—ABCA5—medulla oblongata—epilepsy syndrome	0.00101	0.0242	CbGeAlD
Tacrolimus—PPP3CA—brainstem—epilepsy syndrome	0.000976	0.0235	CbGeAlD
Tacrolimus—PPP3CA—forebrain—epilepsy syndrome	0.000942	0.0226	CbGeAlD
Tacrolimus—ABCA5—midbrain—epilepsy syndrome	0.000921	0.0221	CbGeAlD
Tacrolimus—ABCA5—spinal cord—epilepsy syndrome	0.000898	0.0216	CbGeAlD
Tacrolimus—PPP3CA—telencephalon—epilepsy syndrome	0.000866	0.0208	CbGeAlD
Tacrolimus—Pimecrolimus—MTOR—epilepsy syndrome	0.000824	0.228	CrCbGaD
Tacrolimus—Everolimus—MTOR—epilepsy syndrome	0.000824	0.228	CrCbGaD
Tacrolimus—ABCA5—head—epilepsy syndrome	0.000798	0.0192	CbGeAlD
Tacrolimus—ABCA5—nervous system—epilepsy syndrome	0.000757	0.0182	CbGeAlD
Tacrolimus—ABCA5—central nervous system—epilepsy syndrome	0.000729	0.0175	CbGeAlD
Tacrolimus—MTOR—brainstem—epilepsy syndrome	0.000721	0.0173	CbGeAlD
Tacrolimus—ABCA5—cerebellum—epilepsy syndrome	0.000712	0.0171	CbGeAlD
Tacrolimus—MTOR—forebrain—epilepsy syndrome	0.000696	0.0167	CbGeAlD
Tacrolimus—PPP3CA—medulla oblongata—epilepsy syndrome	0.000681	0.0164	CbGeAlD
Tacrolimus—MTOR—telencephalon—epilepsy syndrome	0.00064	0.0154	CbGeAlD
Tacrolimus—FKBP1A—forebrain—epilepsy syndrome	0.000626	0.015	CbGeAlD
Tacrolimus—PPP3CA—midbrain—epilepsy syndrome	0.000622	0.015	CbGeAlD
Tacrolimus—PPP3CA—spinal cord—epilepsy syndrome	0.000607	0.0146	CbGeAlD
Tacrolimus—Sirolimus—FGF2—epilepsy syndrome	0.000601	0.167	CrCbGaD
Tacrolimus—ABCA5—brain—epilepsy syndrome	0.000579	0.0139	CbGeAlD
Tacrolimus—FKBP1A—telencephalon—epilepsy syndrome	0.000575	0.0138	CbGeAlD
Tacrolimus—Temsirolimus—MTOR—epilepsy syndrome	0.000557	0.154	CrCbGaD
Tacrolimus—PPP3CA—head—epilepsy syndrome	0.000539	0.013	CbGeAlD
Tacrolimus—PPP3CA—nervous system—epilepsy syndrome	0.000511	0.0123	CbGeAlD
Tacrolimus—PPP3CA—central nervous system—epilepsy syndrome	0.000492	0.0118	CbGeAlD
Tacrolimus—Sirolimus—MTOR—epilepsy syndrome	0.00049	0.136	CrCbGaD
Tacrolimus—PPP3CA—cerebellum—epilepsy syndrome	0.000481	0.0116	CbGeAlD
Tacrolimus—FKBP1A—medulla oblongata—epilepsy syndrome	0.000452	0.0109	CbGeAlD
Tacrolimus—MTOR—spinal cord—epilepsy syndrome	0.000448	0.0108	CbGeAlD
Tacrolimus—FKBP1A—midbrain—epilepsy syndrome	0.000413	0.00993	CbGeAlD
Tacrolimus—FKBP1A—spinal cord—epilepsy syndrome	0.000403	0.00969	CbGeAlD
Tacrolimus—MTOR—head—epilepsy syndrome	0.000398	0.00958	CbGeAlD
Tacrolimus—PPP3CA—brain—epilepsy syndrome	0.000391	0.0094	CbGeAlD
Tacrolimus—MTOR—nervous system—epilepsy syndrome	0.000378	0.00908	CbGeAlD
Tacrolimus—MTOR—central nervous system—epilepsy syndrome	0.000364	0.00874	CbGeAlD
Tacrolimus—FKBP1A—head—epilepsy syndrome	0.000358	0.00861	CbGeAlD
Tacrolimus—MTOR—cerebellum—epilepsy syndrome	0.000355	0.00854	CbGeAlD
Tacrolimus—FKBP1A—nervous system—epilepsy syndrome	0.00034	0.00817	CbGeAlD
Tacrolimus—FKBP1A—central nervous system—epilepsy syndrome	0.000327	0.00786	CbGeAlD
Tacrolimus—FKBP1A—cerebellum—epilepsy syndrome	0.00032	0.00769	CbGeAlD
Tacrolimus—ORM1—spinal cord—epilepsy syndrome	0.000316	0.00759	CbGeAlD
Tacrolimus—MTOR—brain—epilepsy syndrome	0.000289	0.00694	CbGeAlD
Tacrolimus—ORM1—nervous system—epilepsy syndrome	0.000266	0.00639	CbGeAlD
Tacrolimus—FKBP1A—brain—epilepsy syndrome	0.00026	0.00624	CbGeAlD
Tacrolimus—ORM1—central nervous system—epilepsy syndrome	0.000256	0.00616	CbGeAlD
Tacrolimus—ALB—brain—epilepsy syndrome	0.000178	0.00429	CbGeAlD
Tacrolimus—ABCB1—forebrain—epilepsy syndrome	0.000145	0.00348	CbGeAlD
Tacrolimus—Temsirolimus—CYP2D6—epilepsy syndrome	0.000134	0.0371	CrCbGaD
Tacrolimus—ABCB1—telencephalon—epilepsy syndrome	0.000133	0.0032	CbGeAlD
Tacrolimus—CYP3A4—nervous system—epilepsy syndrome	0.000111	0.00267	CbGeAlD
Tacrolimus—CYP3A4—central nervous system—epilepsy syndrome	0.000107	0.00257	CbGeAlD
Tacrolimus—ABCB1—medulla oblongata—epilepsy syndrome	0.000105	0.00251	CbGeAlD
Tacrolimus—Temsirolimus—ABCB1—epilepsy syndrome	9.57e-05	0.0265	CrCbGaD
Tacrolimus—ABCB1—midbrain—epilepsy syndrome	9.56e-05	0.0023	CbGeAlD
Tacrolimus—ABCB1—spinal cord—epilepsy syndrome	9.33e-05	0.00224	CbGeAlD
Tacrolimus—Sirolimus—ABCB1—epilepsy syndrome	8.43e-05	0.0233	CrCbGaD
Tacrolimus—ABCB1—head—epilepsy syndrome	8.29e-05	0.00199	CbGeAlD
Tacrolimus—ABCB1—nervous system—epilepsy syndrome	7.86e-05	0.00189	CbGeAlD
Tacrolimus—ABCB1—central nervous system—epilepsy syndrome	7.57e-05	0.00182	CbGeAlD
Tacrolimus—ABCB1—cerebellum—epilepsy syndrome	7.4e-05	0.00178	CbGeAlD
Tacrolimus—ABCB1—brain—epilepsy syndrome	6.01e-05	0.00144	CbGeAlD
Tacrolimus—Hypotension—Valproic Acid—epilepsy syndrome	1.6e-05	8.88e-05	CcSEcCtD
Tacrolimus—Asthenia—Carbamazepine—epilepsy syndrome	1.6e-05	8.88e-05	CcSEcCtD
Tacrolimus—Agitation—Gabapentin—epilepsy syndrome	1.6e-05	8.87e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Phenytoin—epilepsy syndrome	1.6e-05	8.87e-05	CcSEcCtD
Tacrolimus—Discomfort—Pregabalin—epilepsy syndrome	1.6e-05	8.85e-05	CcSEcCtD
Tacrolimus—Nausea—Fosphenytoin—epilepsy syndrome	1.6e-05	8.84e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.59e-05	8.82e-05	CcSEcCtD
Tacrolimus—Erythema multiforme—Topiramate—epilepsy syndrome	1.59e-05	8.82e-05	CcSEcCtD
Tacrolimus—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.59e-05	8.81e-05	CcSEcCtD
Tacrolimus—Vomiting—Felbamate—epilepsy syndrome	1.59e-05	8.79e-05	CcSEcCtD
Tacrolimus—Dry mouth—Pregabalin—epilepsy syndrome	1.58e-05	8.76e-05	CcSEcCtD
Tacrolimus—Pruritus—Carbamazepine—epilepsy syndrome	1.58e-05	8.75e-05	CcSEcCtD
Tacrolimus—Rash—Felbamate—epilepsy syndrome	1.57e-05	8.72e-05	CcSEcCtD
Tacrolimus—Eye disorder—Topiramate—epilepsy syndrome	1.57e-05	8.72e-05	CcSEcCtD
Tacrolimus—Dermatitis—Felbamate—epilepsy syndrome	1.57e-05	8.71e-05	CcSEcCtD
Tacrolimus—Malaise—Gabapentin—epilepsy syndrome	1.57e-05	8.7e-05	CcSEcCtD
Tacrolimus—Tinnitus—Topiramate—epilepsy syndrome	1.57e-05	8.7e-05	CcSEcCtD
Tacrolimus—Vertigo—Gabapentin—epilepsy syndrome	1.56e-05	8.67e-05	CcSEcCtD
Tacrolimus—Headache—Felbamate—epilepsy syndrome	1.56e-05	8.66e-05	CcSEcCtD
Tacrolimus—Confusional state—Pregabalin—epilepsy syndrome	1.56e-05	8.66e-05	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.56e-05	8.66e-05	CcSEcCtD
Tacrolimus—Cardiac disorder—Topiramate—epilepsy syndrome	1.56e-05	8.66e-05	CcSEcCtD
Tacrolimus—Flushing—Topiramate—epilepsy syndrome	1.56e-05	8.66e-05	CcSEcCtD
Tacrolimus—Syncope—Gabapentin—epilepsy syndrome	1.56e-05	8.65e-05	CcSEcCtD
Tacrolimus—Leukopenia—Gabapentin—epilepsy syndrome	1.56e-05	8.64e-05	CcSEcCtD
Tacrolimus—Dizziness—Clonazepam—epilepsy syndrome	1.56e-05	8.63e-05	CcSEcCtD
Tacrolimus—Nausea—Vigabatrin—epilepsy syndrome	1.56e-05	8.62e-05	CcSEcCtD
Tacrolimus—Vomiting—Zonisamide—epilepsy syndrome	1.55e-05	8.61e-05	CcSEcCtD
Tacrolimus—Insomnia—Valproic Acid—epilepsy syndrome	1.55e-05	8.59e-05	CcSEcCtD
Tacrolimus—Oedema—Pregabalin—epilepsy syndrome	1.55e-05	8.59e-05	CcSEcCtD
Tacrolimus—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.55e-05	8.59e-05	CcSEcCtD
Tacrolimus—Asthenia—Lamotrigine—epilepsy syndrome	1.55e-05	8.58e-05	CcSEcCtD
Tacrolimus—Dizziness—Phenytoin—epilepsy syndrome	1.55e-05	8.57e-05	CcSEcCtD
Tacrolimus—Rash—Zonisamide—epilepsy syndrome	1.54e-05	8.54e-05	CcSEcCtD
Tacrolimus—Infection—Pregabalin—epilepsy syndrome	1.54e-05	8.53e-05	CcSEcCtD
Tacrolimus—Paraesthesia—Valproic Acid—epilepsy syndrome	1.54e-05	8.53e-05	CcSEcCtD
Tacrolimus—Palpitations—Gabapentin—epilepsy syndrome	1.54e-05	8.53e-05	CcSEcCtD
Tacrolimus—Dermatitis—Zonisamide—epilepsy syndrome	1.54e-05	8.53e-05	CcSEcCtD
Tacrolimus—Dizziness—Oxcarbazepine—epilepsy syndrome	1.54e-05	8.52e-05	CcSEcCtD
Tacrolimus—Nausea—Diazepam—epilepsy syndrome	1.53e-05	8.49e-05	CcSEcCtD
Tacrolimus—Loss of consciousness—Gabapentin—epilepsy syndrome	1.53e-05	8.48e-05	CcSEcCtD
Tacrolimus—Headache—Zonisamide—epilepsy syndrome	1.53e-05	8.48e-05	CcSEcCtD
Tacrolimus—Dyspnoea—Valproic Acid—epilepsy syndrome	1.53e-05	8.47e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Carbamazepine—epilepsy syndrome	1.53e-05	8.46e-05	CcSEcCtD
Tacrolimus—Angiopathy—Topiramate—epilepsy syndrome	1.53e-05	8.46e-05	CcSEcCtD
Tacrolimus—Pruritus—Lamotrigine—epilepsy syndrome	1.53e-05	8.46e-05	CcSEcCtD
Tacrolimus—Shock—Pregabalin—epilepsy syndrome	1.52e-05	8.45e-05	CcSEcCtD
Tacrolimus—Somnolence—Valproic Acid—epilepsy syndrome	1.52e-05	8.45e-05	CcSEcCtD
Tacrolimus—Immune system disorder—Topiramate—epilepsy syndrome	1.52e-05	8.42e-05	CcSEcCtD
Tacrolimus—Nervous system disorder—Pregabalin—epilepsy syndrome	1.52e-05	8.42e-05	CcSEcCtD
Tacrolimus—Cough—Gabapentin—epilepsy syndrome	1.52e-05	8.42e-05	CcSEcCtD
Tacrolimus—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.52e-05	8.41e-05	CcSEcCtD
Tacrolimus—Mediastinal disorder—Topiramate—epilepsy syndrome	1.52e-05	8.4e-05	CcSEcCtD
Tacrolimus—Tachycardia—Pregabalin—epilepsy syndrome	1.51e-05	8.38e-05	CcSEcCtD
Tacrolimus—Chills—Topiramate—epilepsy syndrome	1.51e-05	8.37e-05	CcSEcCtD
Tacrolimus—Dyspepsia—Valproic Acid—epilepsy syndrome	1.51e-05	8.36e-05	CcSEcCtD
Tacrolimus—Convulsion—Gabapentin—epilepsy syndrome	1.51e-05	8.36e-05	CcSEcCtD
Tacrolimus—Skin disorder—Pregabalin—epilepsy syndrome	1.5e-05	8.34e-05	CcSEcCtD
Tacrolimus—Hypertension—Gabapentin—epilepsy syndrome	1.5e-05	8.33e-05	CcSEcCtD
Tacrolimus—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.5e-05	8.3e-05	CcSEcCtD
Tacrolimus—Vomiting—Clonazepam—epilepsy syndrome	1.5e-05	8.3e-05	CcSEcCtD
Tacrolimus—Decreased appetite—Valproic Acid—epilepsy syndrome	1.49e-05	8.26e-05	CcSEcCtD
Tacrolimus—Alopecia—Topiramate—epilepsy syndrome	1.49e-05	8.24e-05	CcSEcCtD
Tacrolimus—Vomiting—Phenytoin—epilepsy syndrome	1.49e-05	8.24e-05	CcSEcCtD
Tacrolimus—Rash—Clonazepam—epilepsy syndrome	1.48e-05	8.23e-05	CcSEcCtD
Tacrolimus—Dermatitis—Clonazepam—epilepsy syndrome	1.48e-05	8.22e-05	CcSEcCtD
Tacrolimus—Arthralgia—Gabapentin—epilepsy syndrome	1.48e-05	8.22e-05	CcSEcCtD
Tacrolimus—Myalgia—Gabapentin—epilepsy syndrome	1.48e-05	8.22e-05	CcSEcCtD
Tacrolimus—Chest pain—Gabapentin—epilepsy syndrome	1.48e-05	8.22e-05	CcSEcCtD
Tacrolimus—Nausea—Felbamate—epilepsy syndrome	1.48e-05	8.21e-05	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.48e-05	8.2e-05	CcSEcCtD
Tacrolimus—Vomiting—Oxcarbazepine—epilepsy syndrome	1.48e-05	8.2e-05	CcSEcCtD
Tacrolimus—Fatigue—Valproic Acid—epilepsy syndrome	1.48e-05	8.19e-05	CcSEcCtD
Tacrolimus—Anxiety—Gabapentin—epilepsy syndrome	1.48e-05	8.19e-05	CcSEcCtD
Tacrolimus—Anorexia—Pregabalin—epilepsy syndrome	1.48e-05	8.19e-05	CcSEcCtD
Tacrolimus—Dizziness—Carbamazepine—epilepsy syndrome	1.48e-05	8.18e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Lamotrigine—epilepsy syndrome	1.48e-05	8.18e-05	CcSEcCtD
Tacrolimus—Headache—Clonazepam—epilepsy syndrome	1.47e-05	8.17e-05	CcSEcCtD
Tacrolimus—Rash—Phenytoin—epilepsy syndrome	1.47e-05	8.17e-05	CcSEcCtD
Tacrolimus—Mental disorder—Topiramate—epilepsy syndrome	1.47e-05	8.17e-05	CcSEcCtD
Tacrolimus—Dermatitis—Phenytoin—epilepsy syndrome	1.47e-05	8.16e-05	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.47e-05	8.16e-05	CcSEcCtD
Tacrolimus—Rash—Oxcarbazepine—epilepsy syndrome	1.47e-05	8.13e-05	CcSEcCtD
Tacrolimus—Pain—Valproic Acid—epilepsy syndrome	1.47e-05	8.12e-05	CcSEcCtD
Tacrolimus—Constipation—Valproic Acid—epilepsy syndrome	1.47e-05	8.12e-05	CcSEcCtD
Tacrolimus—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.46e-05	8.12e-05	CcSEcCtD
Tacrolimus—Headache—Phenytoin—epilepsy syndrome	1.46e-05	8.12e-05	CcSEcCtD
Tacrolimus—Malnutrition—Topiramate—epilepsy syndrome	1.46e-05	8.12e-05	CcSEcCtD
Tacrolimus—Erythema—Topiramate—epilepsy syndrome	1.46e-05	8.12e-05	CcSEcCtD
Tacrolimus—Discomfort—Gabapentin—epilepsy syndrome	1.46e-05	8.12e-05	CcSEcCtD
Tacrolimus—Headache—Oxcarbazepine—epilepsy syndrome	1.46e-05	8.08e-05	CcSEcCtD
Tacrolimus—Nausea—Zonisamide—epilepsy syndrome	1.45e-05	8.04e-05	CcSEcCtD
Tacrolimus—Dry mouth—Gabapentin—epilepsy syndrome	1.45e-05	8.03e-05	CcSEcCtD
Tacrolimus—Hypotension—Pregabalin—epilepsy syndrome	1.45e-05	8.03e-05	CcSEcCtD
Tacrolimus—Flatulence—Topiramate—epilepsy syndrome	1.44e-05	8e-05	CcSEcCtD
Tacrolimus—Tension—Topiramate—epilepsy syndrome	1.44e-05	7.97e-05	CcSEcCtD
Tacrolimus—Dysgeusia—Topiramate—epilepsy syndrome	1.43e-05	7.95e-05	CcSEcCtD
Tacrolimus—Confusional state—Gabapentin—epilepsy syndrome	1.43e-05	7.94e-05	CcSEcCtD
Tacrolimus—Dizziness—Lamotrigine—epilepsy syndrome	1.43e-05	7.91e-05	CcSEcCtD
Tacrolimus—Nervousness—Topiramate—epilepsy syndrome	1.42e-05	7.88e-05	CcSEcCtD
Tacrolimus—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.42e-05	7.88e-05	CcSEcCtD
Tacrolimus—Oedema—Gabapentin—epilepsy syndrome	1.42e-05	7.88e-05	CcSEcCtD
Tacrolimus—Vomiting—Carbamazepine—epilepsy syndrome	1.42e-05	7.86e-05	CcSEcCtD
Tacrolimus—Back pain—Topiramate—epilepsy syndrome	1.42e-05	7.85e-05	CcSEcCtD
Tacrolimus—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.41e-05	7.83e-05	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.41e-05	7.82e-05	CcSEcCtD
Tacrolimus—Infection—Gabapentin—epilepsy syndrome	1.41e-05	7.82e-05	CcSEcCtD
Tacrolimus—Muscle spasms—Topiramate—epilepsy syndrome	1.41e-05	7.81e-05	CcSEcCtD
Tacrolimus—Rash—Carbamazepine—epilepsy syndrome	1.41e-05	7.8e-05	CcSEcCtD
Tacrolimus—Dermatitis—Carbamazepine—epilepsy syndrome	1.41e-05	7.79e-05	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.4e-05	7.77e-05	CcSEcCtD
Tacrolimus—Insomnia—Pregabalin—epilepsy syndrome	1.4e-05	7.77e-05	CcSEcCtD
Tacrolimus—Nausea—Clonazepam—epilepsy syndrome	1.4e-05	7.75e-05	CcSEcCtD
Tacrolimus—Headache—Carbamazepine—epilepsy syndrome	1.4e-05	7.75e-05	CcSEcCtD
Tacrolimus—Shock—Gabapentin—epilepsy syndrome	1.4e-05	7.75e-05	CcSEcCtD
Tacrolimus—Nervous system disorder—Gabapentin—epilepsy syndrome	1.39e-05	7.72e-05	CcSEcCtD
Tacrolimus—Paraesthesia—Pregabalin—epilepsy syndrome	1.39e-05	7.71e-05	CcSEcCtD
Tacrolimus—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.39e-05	7.71e-05	CcSEcCtD
Tacrolimus—Nausea—Phenytoin—epilepsy syndrome	1.39e-05	7.7e-05	CcSEcCtD
Tacrolimus—Tachycardia—Gabapentin—epilepsy syndrome	1.39e-05	7.69e-05	CcSEcCtD
Tacrolimus—Dyspnoea—Pregabalin—epilepsy syndrome	1.38e-05	7.66e-05	CcSEcCtD
Tacrolimus—Nausea—Oxcarbazepine—epilepsy syndrome	1.38e-05	7.66e-05	CcSEcCtD
Tacrolimus—Vision blurred—Topiramate—epilepsy syndrome	1.38e-05	7.65e-05	CcSEcCtD
Tacrolimus—Skin disorder—Gabapentin—epilepsy syndrome	1.38e-05	7.65e-05	CcSEcCtD
Tacrolimus—Somnolence—Pregabalin—epilepsy syndrome	1.38e-05	7.64e-05	CcSEcCtD
Tacrolimus—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.37e-05	7.61e-05	CcSEcCtD
Tacrolimus—Tremor—Topiramate—epilepsy syndrome	1.37e-05	7.61e-05	CcSEcCtD
Tacrolimus—Vomiting—Lamotrigine—epilepsy syndrome	1.37e-05	7.6e-05	CcSEcCtD
Tacrolimus—Urticaria—Valproic Acid—epilepsy syndrome	1.36e-05	7.55e-05	CcSEcCtD
Tacrolimus—Rash—Lamotrigine—epilepsy syndrome	1.36e-05	7.54e-05	CcSEcCtD
Tacrolimus—Ill-defined disorder—Topiramate—epilepsy syndrome	1.36e-05	7.53e-05	CcSEcCtD
Tacrolimus—Dermatitis—Lamotrigine—epilepsy syndrome	1.36e-05	7.53e-05	CcSEcCtD
Tacrolimus—Abdominal pain—Valproic Acid—epilepsy syndrome	1.35e-05	7.51e-05	CcSEcCtD
Tacrolimus—Body temperature increased—Valproic Acid—epilepsy syndrome	1.35e-05	7.51e-05	CcSEcCtD
Tacrolimus—Anorexia—Gabapentin—epilepsy syndrome	1.35e-05	7.51e-05	CcSEcCtD
Tacrolimus—Anaemia—Topiramate—epilepsy syndrome	1.35e-05	7.5e-05	CcSEcCtD
Tacrolimus—Headache—Lamotrigine—epilepsy syndrome	1.35e-05	7.49e-05	CcSEcCtD
Tacrolimus—Decreased appetite—Pregabalin—epilepsy syndrome	1.35e-05	7.47e-05	CcSEcCtD
Tacrolimus—Agitation—Topiramate—epilepsy syndrome	1.35e-05	7.46e-05	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.34e-05	7.41e-05	CcSEcCtD
Tacrolimus—Fatigue—Pregabalin—epilepsy syndrome	1.34e-05	7.4e-05	CcSEcCtD
Tacrolimus—Hypotension—Gabapentin—epilepsy syndrome	1.33e-05	7.36e-05	CcSEcCtD
Tacrolimus—Nausea—Carbamazepine—epilepsy syndrome	1.33e-05	7.35e-05	CcSEcCtD
Tacrolimus—Constipation—Pregabalin—epilepsy syndrome	1.32e-05	7.34e-05	CcSEcCtD
Tacrolimus—Pain—Pregabalin—epilepsy syndrome	1.32e-05	7.34e-05	CcSEcCtD
Tacrolimus—Malaise—Topiramate—epilepsy syndrome	1.32e-05	7.32e-05	CcSEcCtD
Tacrolimus—Vertigo—Topiramate—epilepsy syndrome	1.32e-05	7.29e-05	CcSEcCtD
Tacrolimus—Syncope—Topiramate—epilepsy syndrome	1.31e-05	7.28e-05	CcSEcCtD
Tacrolimus—Leukopenia—Topiramate—epilepsy syndrome	1.31e-05	7.27e-05	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.29e-05	7.18e-05	CcSEcCtD
Tacrolimus—Palpitations—Topiramate—epilepsy syndrome	1.29e-05	7.17e-05	CcSEcCtD
Tacrolimus—Loss of consciousness—Topiramate—epilepsy syndrome	1.29e-05	7.14e-05	CcSEcCtD
Tacrolimus—Insomnia—Gabapentin—epilepsy syndrome	1.28e-05	7.12e-05	CcSEcCtD
Tacrolimus—Nausea—Lamotrigine—epilepsy syndrome	1.28e-05	7.1e-05	CcSEcCtD
Tacrolimus—Cough—Topiramate—epilepsy syndrome	1.28e-05	7.08e-05	CcSEcCtD
Tacrolimus—Feeling abnormal—Pregabalin—epilepsy syndrome	1.28e-05	7.08e-05	CcSEcCtD
Tacrolimus—Paraesthesia—Gabapentin—epilepsy syndrome	1.28e-05	7.07e-05	CcSEcCtD
Tacrolimus—Convulsion—Topiramate—epilepsy syndrome	1.27e-05	7.03e-05	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.27e-05	7.02e-05	CcSEcCtD
Tacrolimus—Dyspnoea—Gabapentin—epilepsy syndrome	1.27e-05	7.02e-05	CcSEcCtD
Tacrolimus—Hypertension—Topiramate—epilepsy syndrome	1.26e-05	7.01e-05	CcSEcCtD
Tacrolimus—Somnolence—Gabapentin—epilepsy syndrome	1.26e-05	7e-05	CcSEcCtD
Tacrolimus—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.26e-05	7e-05	CcSEcCtD
Tacrolimus—Dyspepsia—Gabapentin—epilepsy syndrome	1.25e-05	6.93e-05	CcSEcCtD
Tacrolimus—Arthralgia—Topiramate—epilepsy syndrome	1.25e-05	6.91e-05	CcSEcCtD
Tacrolimus—Chest pain—Topiramate—epilepsy syndrome	1.25e-05	6.91e-05	CcSEcCtD
Tacrolimus—Myalgia—Topiramate—epilepsy syndrome	1.25e-05	6.91e-05	CcSEcCtD
Tacrolimus—Anxiety—Topiramate—epilepsy syndrome	1.24e-05	6.89e-05	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.24e-05	6.86e-05	CcSEcCtD
Tacrolimus—Decreased appetite—Gabapentin—epilepsy syndrome	1.23e-05	6.85e-05	CcSEcCtD
Tacrolimus—Discomfort—Topiramate—epilepsy syndrome	1.23e-05	6.83e-05	CcSEcCtD
Tacrolimus—Urticaria—Pregabalin—epilepsy syndrome	1.23e-05	6.82e-05	CcSEcCtD
Tacrolimus—Asthenia—Valproic Acid—epilepsy syndrome	1.23e-05	6.82e-05	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.23e-05	6.8e-05	CcSEcCtD
Tacrolimus—Fatigue—Gabapentin—epilepsy syndrome	1.22e-05	6.79e-05	CcSEcCtD
Tacrolimus—Abdominal pain—Pregabalin—epilepsy syndrome	1.22e-05	6.79e-05	CcSEcCtD
Tacrolimus—Body temperature increased—Pregabalin—epilepsy syndrome	1.22e-05	6.79e-05	CcSEcCtD
Tacrolimus—Dry mouth—Topiramate—epilepsy syndrome	1.22e-05	6.76e-05	CcSEcCtD
Tacrolimus—Pain—Gabapentin—epilepsy syndrome	1.21e-05	6.73e-05	CcSEcCtD
Tacrolimus—Constipation—Gabapentin—epilepsy syndrome	1.21e-05	6.73e-05	CcSEcCtD
Tacrolimus—Pruritus—Valproic Acid—epilepsy syndrome	1.21e-05	6.72e-05	CcSEcCtD
Tacrolimus—Confusional state—Topiramate—epilepsy syndrome	1.21e-05	6.68e-05	CcSEcCtD
Tacrolimus—Oedema—Topiramate—epilepsy syndrome	1.2e-05	6.63e-05	CcSEcCtD
Tacrolimus—Infection—Topiramate—epilepsy syndrome	1.19e-05	6.58e-05	CcSEcCtD
Tacrolimus—Shock—Topiramate—epilepsy syndrome	1.18e-05	6.52e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Valproic Acid—epilepsy syndrome	1.17e-05	6.5e-05	CcSEcCtD
Tacrolimus—Nervous system disorder—Topiramate—epilepsy syndrome	1.17e-05	6.5e-05	CcSEcCtD
Tacrolimus—Feeling abnormal—Gabapentin—epilepsy syndrome	1.17e-05	6.49e-05	CcSEcCtD
Tacrolimus—Thrombocytopenia—Topiramate—epilepsy syndrome	1.17e-05	6.49e-05	CcSEcCtD
Tacrolimus—Tachycardia—Topiramate—epilepsy syndrome	1.17e-05	6.47e-05	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.16e-05	6.44e-05	CcSEcCtD
Tacrolimus—Skin disorder—Topiramate—epilepsy syndrome	1.16e-05	6.44e-05	CcSEcCtD
Tacrolimus—Hyperhidrosis—Topiramate—epilepsy syndrome	1.16e-05	6.41e-05	CcSEcCtD
Tacrolimus—Hypersensitivity—Pregabalin—epilepsy syndrome	1.14e-05	6.33e-05	CcSEcCtD
Tacrolimus—Anorexia—Topiramate—epilepsy syndrome	1.14e-05	6.32e-05	CcSEcCtD
Tacrolimus—Dizziness—Valproic Acid—epilepsy syndrome	1.13e-05	6.28e-05	CcSEcCtD
Tacrolimus—Urticaria—Gabapentin—epilepsy syndrome	1.13e-05	6.26e-05	CcSEcCtD
Tacrolimus—Abdominal pain—Gabapentin—epilepsy syndrome	1.12e-05	6.23e-05	CcSEcCtD
Tacrolimus—Body temperature increased—Gabapentin—epilepsy syndrome	1.12e-05	6.23e-05	CcSEcCtD
Tacrolimus—Hypotension—Topiramate—epilepsy syndrome	1.12e-05	6.19e-05	CcSEcCtD
Tacrolimus—Asthenia—Pregabalin—epilepsy syndrome	1.11e-05	6.16e-05	CcSEcCtD
Tacrolimus—Pruritus—Pregabalin—epilepsy syndrome	1.1e-05	6.08e-05	CcSEcCtD
Tacrolimus—Vomiting—Valproic Acid—epilepsy syndrome	1.09e-05	6.04e-05	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.09e-05	6.04e-05	CcSEcCtD
Tacrolimus—Insomnia—Topiramate—epilepsy syndrome	1.08e-05	5.99e-05	CcSEcCtD
Tacrolimus—Rash—Valproic Acid—epilepsy syndrome	1.08e-05	5.99e-05	CcSEcCtD
Tacrolimus—Dermatitis—Valproic Acid—epilepsy syndrome	1.08e-05	5.98e-05	CcSEcCtD
Tacrolimus—Headache—Valproic Acid—epilepsy syndrome	1.07e-05	5.95e-05	CcSEcCtD
Tacrolimus—Paraesthesia—Topiramate—epilepsy syndrome	1.07e-05	5.95e-05	CcSEcCtD
Tacrolimus—Dyspnoea—Topiramate—epilepsy syndrome	1.07e-05	5.91e-05	CcSEcCtD
Tacrolimus—Somnolence—Topiramate—epilepsy syndrome	1.06e-05	5.89e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Pregabalin—epilepsy syndrome	1.06e-05	5.88e-05	CcSEcCtD
Tacrolimus—Dyspepsia—Topiramate—epilepsy syndrome	1.05e-05	5.83e-05	CcSEcCtD
Tacrolimus—Hypersensitivity—Gabapentin—epilepsy syndrome	1.05e-05	5.8e-05	CcSEcCtD
Tacrolimus—Decreased appetite—Topiramate—epilepsy syndrome	1.04e-05	5.76e-05	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.03e-05	5.72e-05	CcSEcCtD
Tacrolimus—Fatigue—Topiramate—epilepsy syndrome	1.03e-05	5.71e-05	CcSEcCtD
Tacrolimus—Dizziness—Pregabalin—epilepsy syndrome	1.02e-05	5.68e-05	CcSEcCtD
Tacrolimus—Constipation—Topiramate—epilepsy syndrome	1.02e-05	5.67e-05	CcSEcCtD
Tacrolimus—Pain—Topiramate—epilepsy syndrome	1.02e-05	5.67e-05	CcSEcCtD
Tacrolimus—Asthenia—Gabapentin—epilepsy syndrome	1.02e-05	5.65e-05	CcSEcCtD
Tacrolimus—Nausea—Valproic Acid—epilepsy syndrome	1.02e-05	5.64e-05	CcSEcCtD
Tacrolimus—Pruritus—Gabapentin—epilepsy syndrome	1.01e-05	5.57e-05	CcSEcCtD
Tacrolimus—Vomiting—Pregabalin—epilepsy syndrome	9.85e-06	5.46e-05	CcSEcCtD
Tacrolimus—Feeling abnormal—Topiramate—epilepsy syndrome	9.85e-06	5.46e-05	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Topiramate—epilepsy syndrome	9.77e-06	5.42e-05	CcSEcCtD
Tacrolimus—Rash—Pregabalin—epilepsy syndrome	9.77e-06	5.42e-05	CcSEcCtD
Tacrolimus—Dermatitis—Pregabalin—epilepsy syndrome	9.76e-06	5.41e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Gabapentin—epilepsy syndrome	9.72e-06	5.39e-05	CcSEcCtD
Tacrolimus—Headache—Pregabalin—epilepsy syndrome	9.71e-06	5.38e-05	CcSEcCtD
Tacrolimus—Urticaria—Topiramate—epilepsy syndrome	9.49e-06	5.26e-05	CcSEcCtD
Tacrolimus—Abdominal pain—Topiramate—epilepsy syndrome	9.45e-06	5.24e-05	CcSEcCtD
Tacrolimus—Body temperature increased—Topiramate—epilepsy syndrome	9.45e-06	5.24e-05	CcSEcCtD
Tacrolimus—Dizziness—Gabapentin—epilepsy syndrome	9.39e-06	5.21e-05	CcSEcCtD
Tacrolimus—Nausea—Pregabalin—epilepsy syndrome	9.2e-06	5.1e-05	CcSEcCtD
Tacrolimus—Vomiting—Gabapentin—epilepsy syndrome	9.03e-06	5.01e-05	CcSEcCtD
Tacrolimus—Rash—Gabapentin—epilepsy syndrome	8.96e-06	4.97e-05	CcSEcCtD
Tacrolimus—Dermatitis—Gabapentin—epilepsy syndrome	8.95e-06	4.96e-05	CcSEcCtD
Tacrolimus—Headache—Gabapentin—epilepsy syndrome	8.9e-06	4.93e-05	CcSEcCtD
Tacrolimus—Hypersensitivity—Topiramate—epilepsy syndrome	8.81e-06	4.88e-05	CcSEcCtD
Tacrolimus—Asthenia—Topiramate—epilepsy syndrome	8.58e-06	4.75e-05	CcSEcCtD
Tacrolimus—Pruritus—Topiramate—epilepsy syndrome	8.46e-06	4.69e-05	CcSEcCtD
Tacrolimus—Nausea—Gabapentin—epilepsy syndrome	8.44e-06	4.68e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Topiramate—epilepsy syndrome	8.18e-06	4.53e-05	CcSEcCtD
Tacrolimus—Dizziness—Topiramate—epilepsy syndrome	7.9e-06	4.38e-05	CcSEcCtD
Tacrolimus—Vomiting—Topiramate—epilepsy syndrome	7.6e-06	4.21e-05	CcSEcCtD
Tacrolimus—Rash—Topiramate—epilepsy syndrome	7.54e-06	4.18e-05	CcSEcCtD
Tacrolimus—Dermatitis—Topiramate—epilepsy syndrome	7.53e-06	4.17e-05	CcSEcCtD
Tacrolimus—Headache—Topiramate—epilepsy syndrome	7.49e-06	4.15e-05	CcSEcCtD
Tacrolimus—Nausea—Topiramate—epilepsy syndrome	7.1e-06	3.94e-05	CcSEcCtD
Tacrolimus—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	5.12e-06	7.13e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6ST—epilepsy syndrome	5.11e-06	7.12e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADRA2A—epilepsy syndrome	5.11e-06	7.12e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PLAT—epilepsy syndrome	5.09e-06	7.09e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—YWHAZ—epilepsy syndrome	5.07e-06	7.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	5.07e-06	7.06e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TXNRD1—epilepsy syndrome	5.04e-06	7.03e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—JUN—epilepsy syndrome	5.02e-06	7e-05	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.01e-06	6.98e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	5.01e-06	6.98e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—YWHAZ—epilepsy syndrome	5e-06	6.96e-05	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.97e-06	6.92e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RELA—epilepsy syndrome	4.95e-06	6.9e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—BDKRB2—epilepsy syndrome	4.91e-06	6.84e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL12—epilepsy syndrome	4.91e-06	6.84e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—AKT1—epilepsy syndrome	4.91e-06	6.84e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ADSL—epilepsy syndrome	4.91e-06	6.84e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AQP1—epilepsy syndrome	4.9e-06	6.82e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.89e-06	6.82e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.89e-06	6.82e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.88e-06	6.8e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MTOR—epilepsy syndrome	4.86e-06	6.76e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TSC2—epilepsy syndrome	4.84e-06	6.74e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—epilepsy syndrome	4.84e-06	6.74e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	4.82e-06	6.72e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—JUNB—epilepsy syndrome	4.82e-06	6.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CNR1—epilepsy syndrome	4.82e-06	6.71e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GLUL—epilepsy syndrome	4.81e-06	6.7e-05	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.81e-06	6.7e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CCR5—epilepsy syndrome	4.81e-06	6.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—BCHE—epilepsy syndrome	4.8e-06	6.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PLCB1—epilepsy syndrome	4.8e-06	6.69e-05	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	4.77e-06	6.65e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	4.72e-06	6.58e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR7—epilepsy syndrome	4.7e-06	6.55e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.7e-06	6.55e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	4.7e-06	6.54e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—POMC—epilepsy syndrome	4.68e-06	6.52e-05	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	4.65e-06	6.47e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.6e-06	6.41e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	4.58e-06	6.38e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCL2—epilepsy syndrome	4.58e-06	6.37e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.58e-06	6.37e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HBEGF—epilepsy syndrome	4.57e-06	6.36e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	4.53e-06	6.32e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TH—epilepsy syndrome	4.52e-06	6.29e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—SRC—epilepsy syndrome	4.51e-06	6.28e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PLAU—epilepsy syndrome	4.5e-06	6.27e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AKT3—epilepsy syndrome	4.48e-06	6.24e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TSC2—epilepsy syndrome	4.47e-06	6.22e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PRKCB—epilepsy syndrome	4.47e-06	6.22e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CASP3—epilepsy syndrome	4.47e-06	6.22e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6ST—epilepsy syndrome	4.45e-06	6.2e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—KCNJ11—epilepsy syndrome	4.43e-06	6.17e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CHRM3—epilepsy syndrome	4.43e-06	6.17e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4.42e-06	6.16e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.39e-06	6.12e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADAM10—epilepsy syndrome	4.38e-06	6.1e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APOE—epilepsy syndrome	4.37e-06	6.09e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.36e-06	6.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.36e-06	6.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.36e-06	6.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.36e-06	6.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.36e-06	6.08e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.35e-06	6.06e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—JUN—epilepsy syndrome	4.34e-06	6.04e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—SRC—epilepsy syndrome	4.33e-06	6.03e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—SRC—epilepsy syndrome	4.31e-06	6e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AQP1—epilepsy syndrome	4.29e-06	5.98e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP9—epilepsy syndrome	4.22e-06	5.88e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	4.19e-06	5.84e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PRKCB—epilepsy syndrome	4.19e-06	5.83e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—S100B—epilepsy syndrome	4.14e-06	5.77e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FGF2—epilepsy syndrome	4.14e-06	5.76e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS2—epilepsy syndrome	4.14e-06	5.76e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.12e-06	5.74e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6ST—epilepsy syndrome	4.11e-06	5.72e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SOCS3—epilepsy syndrome	4.1e-06	5.71e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—AKT1—epilepsy syndrome	4.09e-06	5.7e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CDC42—epilepsy syndrome	4.09e-06	5.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	4.08e-06	5.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FOS—epilepsy syndrome	4.08e-06	5.68e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS2—epilepsy syndrome	4.07e-06	5.68e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	4.06e-06	5.65e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.04e-06	5.63e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.99e-06	5.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.99e-06	5.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.99e-06	5.56e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CASP8—epilepsy syndrome	3.98e-06	5.55e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AVP—epilepsy syndrome	3.96e-06	5.51e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.92e-06	5.46e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SRC—epilepsy syndrome	3.89e-06	5.42e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.88e-06	5.4e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.88e-06	5.4e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.84e-06	5.35e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RELA—epilepsy syndrome	3.84e-06	5.35e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VEGFA—epilepsy syndrome	3.79e-06	5.28e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	3.77e-06	5.25e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MTOR—epilepsy syndrome	3.77e-06	5.24e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HES1—epilepsy syndrome	3.74e-06	5.21e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—AKT1—epilepsy syndrome	3.74e-06	5.21e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CAT—epilepsy syndrome	3.72e-06	5.18e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.71e-06	5.17e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.71e-06	5.17e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	3.66e-06	5.1e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FYN—epilepsy syndrome	3.64e-06	5.07e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—H2AFX—epilepsy syndrome	3.63e-06	5.05e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MEF2C—epilepsy syndrome	3.62e-06	5.04e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	3.62e-06	5.04e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ABCG2—epilepsy syndrome	3.61e-06	5.03e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FGF2—epilepsy syndrome	3.6e-06	5.01e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP2C19—epilepsy syndrome	3.52e-06	4.9e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—YWHAZ—epilepsy syndrome	3.5e-06	4.87e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP11A1—epilepsy syndrome	3.5e-06	4.87e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.49e-06	4.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	3.49e-06	4.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—BCHE—epilepsy syndrome	3.47e-06	4.84e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.47e-06	4.83e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CASP3—epilepsy syndrome	3.46e-06	4.82e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NGF—epilepsy syndrome	3.46e-06	4.82e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—AKT1—epilepsy syndrome	3.45e-06	4.81e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—BCL2—epilepsy syndrome	3.42e-06	4.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.39e-06	4.73e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCR5—epilepsy syndrome	3.37e-06	4.69e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GPX1—epilepsy syndrome	3.36e-06	4.69e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—JUN—epilepsy syndrome	3.36e-06	4.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—RELA—epilepsy syndrome	3.34e-06	4.65e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—FGF2—epilepsy syndrome	3.32e-06	4.63e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	3.31e-06	4.62e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.31e-06	4.61e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.31e-06	4.61e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR2A—epilepsy syndrome	3.29e-06	4.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	3.28e-06	4.56e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—epilepsy syndrome	3.27e-06	4.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TH—epilepsy syndrome	3.27e-06	4.55e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.16e-06	4.41e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP2D6—epilepsy syndrome	3.16e-06	4.4e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.15e-06	4.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.15e-06	4.39e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TSC2—epilepsy syndrome	3.13e-06	4.36e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AGT—epilepsy syndrome	3.13e-06	4.35e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.09e-06	4.3e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.08e-06	4.29e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.06e-06	4.27e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOE—epilepsy syndrome	3.06e-06	4.27e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.02e-06	4.21e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—epilepsy syndrome	3.02e-06	4.21e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SRC—epilepsy syndrome	3.02e-06	4.2e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ADRA2A—epilepsy syndrome	3e-06	4.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KDR—epilepsy syndrome	3e-06	4.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—epilepsy syndrome	3e-06	4.17e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—BCHE—epilepsy syndrome	2.99e-06	4.17e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.97e-06	4.13e-05	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.97e-06	4.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AGT—epilepsy syndrome	2.95e-06	4.11e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.94e-06	4.09e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—JUN—epilepsy syndrome	2.93e-06	4.08e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.92e-06	4.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.91e-06	4.05e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOE—epilepsy syndrome	2.89e-06	4.03e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRKCB—epilepsy syndrome	2.89e-06	4.02e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6ST—epilepsy syndrome	2.88e-06	4.01e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC2A1—epilepsy syndrome	2.85e-06	3.97e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PLCB1—epilepsy syndrome	2.82e-06	3.93e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TH—epilepsy syndrome	2.81e-06	3.92e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—AKT1—epilepsy syndrome	2.8e-06	3.9e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.77e-06	3.86e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.76e-06	3.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.73e-06	3.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.72e-06	3.79e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—AKT1—epilepsy syndrome	2.69e-06	3.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.69e-06	3.75e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—AKT1—epilepsy syndrome	2.68e-06	3.73e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.64e-06	3.68e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.64e-06	3.67e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.63e-06	3.67e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—POMC—epilepsy syndrome	2.63e-06	3.66e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—SRC—epilepsy syndrome	2.62e-06	3.66e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.62e-06	3.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.62e-06	3.64e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL2—epilepsy syndrome	2.57e-06	3.59e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.5e-06	3.48e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—POMC—epilepsy syndrome	2.48e-06	3.46e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.47e-06	3.44e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TH—epilepsy syndrome	2.46e-06	3.43e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SRC—epilepsy syndrome	2.46e-06	3.43e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.43e-06	3.39e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SRC—epilepsy syndrome	2.42e-06	3.38e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AKT1—epilepsy syndrome	2.42e-06	3.37e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—epilepsy syndrome	2.4e-06	3.34e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.39e-06	3.33e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.39e-06	3.33e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HMOX1—epilepsy syndrome	2.35e-06	3.27e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGF2—epilepsy syndrome	2.33e-06	3.24e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CAT—epilepsy syndrome	2.32e-06	3.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—epilepsy syndrome	2.26e-06	3.15e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ABCB1—epilepsy syndrome	2.25e-06	3.14e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RELA—epilepsy syndrome	2.16e-06	3.01e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.13e-06	2.97e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GPX1—epilepsy syndrome	2.09e-06	2.92e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.09e-06	2.91e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.06e-06	2.86e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CAT—epilepsy syndrome	2.03e-06	2.83e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.98e-06	2.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.95e-06	2.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CASP3—epilepsy syndrome	1.95e-06	2.71e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.9e-06	2.65e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—JUN—epilepsy syndrome	1.89e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.89e-06	2.63e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AKT1—epilepsy syndrome	1.88e-06	2.61e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—epilepsy syndrome	1.84e-06	2.56e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AGT—epilepsy syndrome	1.84e-06	2.56e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.84e-06	2.56e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOE—epilepsy syndrome	1.8e-06	2.51e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.79e-06	2.5e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.7e-06	2.37e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SRC—epilepsy syndrome	1.7e-06	2.36e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—epilepsy syndrome	1.65e-06	2.3e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.64e-06	2.28e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—AKT1—epilepsy syndrome	1.63e-06	2.27e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.62e-06	2.26e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.61e-06	2.25e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AGT—epilepsy syndrome	1.61e-06	2.24e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOE—epilepsy syndrome	1.58e-06	2.2e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—POMC—epilepsy syndrome	1.55e-06	2.15e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.54e-06	2.15e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—AKT1—epilepsy syndrome	1.53e-06	2.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.52e-06	2.12e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TH—epilepsy syndrome	1.52e-06	2.11e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—AKT1—epilepsy syndrome	1.51e-06	2.1e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.43e-06	1.99e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—POMC—epilepsy syndrome	1.35e-06	1.89e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.27e-06	1.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.25e-06	1.74e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—epilepsy syndrome	1.23e-06	1.72e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—epilepsy syndrome	1.23e-06	1.72e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.22e-06	1.69e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.13e-06	1.57e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	1.5e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AKT1—epilepsy syndrome	1.05e-06	1.47e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AKT1—epilepsy syndrome	9.95e-07	1.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AGT—epilepsy syndrome	9.91e-07	1.38e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.71e-07	1.35e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.34e-07	1.16e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.61e-07	1.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AKT1—epilepsy syndrome	7.2e-07	1e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.66e-07	9.27e-06	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AKT1—epilepsy syndrome	6.2e-07	8.63e-06	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.43e-07	7.56e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.35e-07	4.66e-06	CbGpPWpGaD
